{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:23:37Z","timestamp":1765887817518},"reference-count":40,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.07.057","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T01:24:40Z","timestamp":1472606680000},"page":"4843-4849","source":"Crossref","is-referenced-by-count":51,"title":["Challenges and opportunities in RSV vaccine development: Meeting report from FDA\/NIH workshop"],"prefix":"10.1016","volume":"34","author":[{"given":"Jeffrey N.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barney S.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth A.","family":"Karron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann R.","family":"Falsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonnie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy A.","family":"Beeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2016.07.057_b0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/modpathol.3800725","article-title":"The histopathology of fatal untreated human respiratory syncytial virus infection","volume":"20","author":"Johnson","year":"2007","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.057_b0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1513\/pats.200501-002AW","article-title":"Pathogenesis of respiratory syncytial virus infection in the murine model","volume":"2","author":"Peebles","year":"2005","journal-title":"Proc Am Thorac Soc"},{"issue":"9725","key":"10.1016\/j.vaccine.2016.07.057_b0015","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2016.07.057_b0020","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","article-title":"Bronchiolitis-associated hospitalizations among US children, 1980\u20131996","volume":"282","author":"Shay","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2016.07.057_b0025","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2016.07.057_b0030","article-title":"Prospective clinical and serological follow-up in early childhood reveals a high rate of subclinical RSV infection and a relatively high reinfection rate within the first 3 years of life","volume":"1\u201312","author":"Kutsaya","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"17","key":"10.1016\/j.vaccine.2016.07.057_b0035","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.057_b0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.057_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/CVI.00609-15","article-title":"Brief history and characterization of enhanced respiratory syncytial virus disease","volume":"23","author":"Acosta","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"30","key":"10.1016\/j.vaccine.2016.07.057_b0050","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/j.vaccine.2016.04.083","article-title":"Vaccines against respiratory syncytial virus: the time has finally come","volume":"34","author":"Graham","year":"2016","journal-title":"Vaccine"},{"issue":"309","key":"10.1016\/j.vaccine.2016.07.057_b0055","doi-asserted-by":"crossref","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.vaccine.2016.07.057_b0060","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/infdis\/169.6.1368","article-title":"Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin","volume":"169","author":"Siber","year":"1994","journal-title":"J Infect Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2016.07.057_b0065","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children","volume":"329","author":"Groothuis","year":"1993","journal-title":"New Engl J Med"},{"issue":"3 Pt 1","key":"10.1016\/j.vaccine.2016.07.057_b0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","author":"The IMpact-RSV Study Group","year":"1998","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.057_b0075","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","article-title":"Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus","volume":"191","author":"Habibi","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"42","key":"10.1016\/j.vaccine.2016.07.057_b0080","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/j.vaccine.2007.08.014","article-title":"The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines","volume":"25","author":"Wright","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.057_b0085","article-title":"WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization meeting held on 23\u201324 March 2015","author":"Modjarrad","year":"2015","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2016.07.057_b0095","first-page":"1133","article-title":"Centers for Disease C, Prevention. Respiratory syncytial virus\u2013United States, July 2012\u2013June 2014","volume":"63","author":"Haynes","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.057_b0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s004310050798","article-title":"International variation in the management of infants hospitalized with respiratory syncytial virus","volume":"157","author":"Behrendt","year":"1998","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.1016\/j.vaccine.2016.07.057_b0105","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/INF.0000000000000813","article-title":"Clinical endpoints for respiratory syncytial virus prophylaxis trials in infants and children in high and middle income countries","volume":"34","author":"Simoes","year":"2015","journal-title":"Pediat Infect Dis J"},{"issue":"40","key":"10.1016\/j.vaccine.2016.07.057_b0110","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1016\/j.vaccine.2013.07.024","article-title":"Respiratory syncytial virus immunization program for the United States: impact of performance determinants of a theoretical vaccine","volume":"31","author":"Regnier","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2016.07.057_b0115","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2014.12.068","article-title":"Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy","volume":"33","author":"Roberts","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.057_b0120","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","article-title":"Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis","volume":"134","author":"Ralston","year":"2014","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.057_b0125","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/606055","article-title":"Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance","volume":"49","author":"Nokes","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.057_b0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2010.05.026","article-title":"The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children","volume":"126","author":"Simoes","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2016.07.057_b0135","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMc1307429","article-title":"Respiratory syncytial virus and recurrent wheeze","volume":"369","author":"Blanken","year":"2013","journal-title":"New Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2016.07.057_b0140","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S1473-3099(15)00247-9","article-title":"Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial","volume":"15","author":"O\u2019Brien","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"9953","key":"10.1016\/j.vaccine.2016.07.057_b0145","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2016.07.057_b0150","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"New Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2016.07.057_b0155","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/infdis\/jiu316","article-title":"Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh","volume":"210","author":"Chu","year":"2014","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2016.07.057_b0160","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2016.07.057_b0165","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1016\/j.vaccine.2013.07.042","article-title":"Research on vaccines during pregnancy: protocol design and assessment of safety","volume":"31","author":"Munoz","year":"2013","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2016.07.057_b0170","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1016\/j.vaccine.2013.07.031","article-title":"Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments","volume":"31","author":"Sheffield","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.057_b0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/infdis\/jiv406","article-title":"A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age","volume":"213","author":"Glenn","year":"2016","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.057_b0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/421524","article-title":"Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults","volume":"190","author":"Walsh","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.057_b0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/380907","article-title":"Risk factors for severe respiratory syncytial virus infection in elderly persons","volume":"189","author":"Walsh","year":"2004","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.057_b0190","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/infdis\/jit038","article-title":"Viral shedding and immune responses to respiratory syncytial virus infection in older adults","volume":"207","author":"Walsh","year":"2013","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.057_b0195","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/153537020222700912","article-title":"Age-dependent replication of respiratory syncytial virus in the cotton rat","volume":"227","author":"Curtis","year":"2002","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.057_b0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1086\/510628","article-title":"Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment","volume":"195","author":"Boukhvalova","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.07.057_b9000","unstructured":"Qualification Process for Drug Development Tools, <http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM230597.pdf>."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T07:15:47Z","timestamp":1556349347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":40,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16306557"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}